NCT07189962View on ClinicalTrials.gov

A Pharmacokinetic Study of SHR8554 Injection in the Population With Renal Insufficiency and Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 20, 2022

Primary Completion Date

April 13, 2023

Study Completion Date

April 13, 2023

Conditions

Moderate to Severe Postoperative Pain

Interventions

DRUG

SHR8554 Injection

SHR8554 injection.

Trial Locations (1)

266003

The Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY